Targeting vascular endothelial growth factor: a novel approach in the treatment of cancer.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
Works matching IS 10792082 AND DT 2004 AND VI 61 AND IP 21
Results: 29
1
2
Vascular endothelial growth factor as a therapeutic target in cancer.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. S4, doi. 10.1093/ajhp/61.suppl_5.S4
- By:
- Publication type:
- Article
3
Targeting vascular endothelial growth factor: A novel approach in the treatment of cancer.
- Published in:
- 2004
- By:
- Publication type:
- Proceeding
4
Targeting vascular endothelial growth factor: A novel approach in the treatment of cancer.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. S27
- Publication type:
- Article
5
Books Received.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. 2320
- Publication type:
- Article
6
Seamless Care: A Pharmacist's Guide to Continuous Care Programs (Book).
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. 2319
- By:
- Publication type:
- Article
7
Quack, Quack, Quack: The Sellers of Nostrums in Prints, Posters, Ephemera & Books (Book).
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. 2319
- By:
- Publication type:
- Article
8
Medication-related services in a Mexican pediatric hospital.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. 2311, doi. 10.1093/ajhp/61.21.2311
- By:
- Publication type:
- Article
9
Role of the director of pharmacy: The first six months.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. 2297, doi. 10.1093/ajhp/61.21.2297
- By:
- Publication type:
- Article
10
Interdisciplinary education program for nurses and pharmacists.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. 2294, doi. 10.1093/ajhp/61.21.2294
- By:
- Publication type:
- Article
11
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. 2289, doi. 10.1093/ajhp/61.21.2289
- By:
- Publication type:
- Article
12
Predicted serum valproic acid concentrations in patients missing and replacing a dose of extended-release divalproex sodium.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. 2284, doi. 10.1093/ajhp/61.21.2284
- By:
- Publication type:
- Article
13
Patent expiration for lansoprazole.
- Published in:
- 2004
- By:
- Publication type:
- Letter
14
Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. 2272, doi. 10.1093/ajhp/61.21.2272
- By:
- Publication type:
- Article
15
The two i's of pharmacy.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. 2263, doi. 10.1093/ajhp/61.21.2263
- By:
- Publication type:
- Article
16
Assuming the role of a pharmacy director.
- Published in:
- 2004
- By:
- Publication type:
- Editorial
17
Pharmacy residency programs: How to find the one for you.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. 2254, doi. 10.1093/ajhp/61.21.2254
- By:
- Publication type:
- Article
18
Pharmacokinetics and safety of extended-release divalproex sodium tablets: Morning versus evening administration.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. 2280, doi. 10.1093/ajhp/61.21.2280
- By:
- Publication type:
- Article
19
Exact volume in intravenous solution bags.
- Published in:
- 2004
- By:
- Publication type:
- Letter
20
Use of proton-pump inhibitors at a nonprofit, mixed-model health maintenance organization.
- Published in:
- 2004
- By:
- Publication type:
- Letter
21
Corrections.
- Published in:
- 2004
- Publication type:
- Correction Notice
22
Pittsburgh Poison Center is terrorism response leader.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. 2240, doi. 10.1093/ajhp/61.21.2240
- By:
- Publication type:
- Article
23
Appointment.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. 2240, doi. 10.1093/ajhp/61.21.2240a
- Publication type:
- Article
24
Pharmacists around the globe meet in New Orleans.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. 2238, doi. 10.1093/ajhp/61.21.2238
- By:
- Publication type:
- Article
25
New drugs and dosage forms.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. 2236, doi. 10.1093/ajhp/61.21.2236
- Publication type:
- Article
26
MI risk prompts rofecoxib withdrawal.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. 2234, doi. 10.1093/ajhp/61.21.2234
- By:
- Publication type:
- Article
27
Congress investigates FDA's handling of antidepressant safety information.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. 2228, doi. 10.1093/ajhp/61.21.2228
- By:
- Publication type:
- Article
28
Overview of bevacizumab: A new cancer therapeutic strategy targeting vascular endothelial growth factor.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. S21, doi. 10.1093/ajhp/61.suppl_5.S21
- By:
- Publication type:
- Article
29
Update on clinical trials targeting vascular endothelial growth factor in cancer.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 21, p. S12, doi. 10.1093/ajhp/61.suppl_5.S12
- By:
- Publication type:
- Article